Status:
COMPLETED
Prevention of Catheter-Related Bloodstream Infection in Patients With Hemato-Oncological Disease
Lead Sponsor:
Centre National de Greffe de Moelle Osseuse
Conditions:
Infection
Eligibility:
All Genders
4-65 years
Phase:
PHASE3
Brief Summary
The aim of this prospective randomised controlled trial is to compare the incidence of catheter-related bloodstream infection in 2 groups of patients with hemato-oncological disease: Group A: heparin...
Detailed Description
Central venous lines (CVLs) are commonly used in patients with hemato-oncological disease for indications such as monitoring of hemodynamics and administration of blood products, chemotherapy, parente...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients are eligible for the study if they are between 4 and 65 years of age and have a short-term non-tunneled percutaneous CVL.
- Exclusion criteria:
- The presence of a CVL at admission
- An anticipated duration of catheterization of less than 5 days or more than 35 days
- A contraindication to the use of subclavian catheterization due to major blood coagulation disorders (ie, platelet count \< 50 x 10\^9/L)
- Disseminated intravascular coagulation
- Prior allergic reactions to heparin or to CSS
- An aberrant course of the CVL (jugular vein)
- An absence of catheter-tip culture at the time of catheter removal.
Exclusion
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
End Date :
January 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00413738
Start Date
December 1 2006
End Date
January 1 2009
Last Update
January 27 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.